Preventative Options and the Future of Chemoprevention for Cutaneous Tumors.

Dermatol Clin

Research Department, Moy-Fincher-Chipps Facial Plastics & Dermatology, 421 North Rodeo Drive #T-7, Beverly Hills, CA 90210, USA. Electronic address:

Published: January 2023

Chemoprophylaxis against nonmelanoma skin cancer (NMSC) should be considered in high-risk populations such as those with certain genetic disorders, immunosuppressive states, chronic radiation, excessive UV exposure, or extensive personal or family history of NMSC. The methods for chemoprevention have progressed beyond traditional sunscreen into more effective strategies including DNA repair enzymes, nicotinamide, systemic retinoids, and nonsteroidal anti-inflammatory drugs. Other therapies are still being investigated and include treatments that target premalignant lesions, capecitabine, hedgehog inhibitors, difluoromethylornithine, metformin, and nutritional factors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.det.2022.07.020DOI Listing

Publication Analysis

Top Keywords

preventative options
4
options future
4
future chemoprevention
4
chemoprevention cutaneous
4
cutaneous tumors
4
tumors chemoprophylaxis
4
chemoprophylaxis nonmelanoma
4
nonmelanoma skin
4
skin cancer
4
cancer nmsc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!